Browse treatments

…rdless of antibody status, most TDLs patients responded well to immunotherapy, with 86.7% achieving a favourable outcome.Conclusions TDLs rep…

… receptor auto-antibodies, but her condition did not respond to immunotherapy for AMPA receptor encephalitis. Subsequent MR brain scan showed…

… gangrene. She improved after stopping eltrombopag and starting immunotherapy (corticosteroids, intravenous immunoglobulin and rituximab) but…

… of his enlarged left testes showed fibrosis without neoplasia. Immunotherapy so far has not helped significantly.…

…Introduction Immunotherapy combined with chemotherapy has shown potential in improving the pathological complete resp…

…s.1 Currently, the standard of care for PDAC primarily involves chemotherapy, and immunotherapy has yet to show significant benefits in this…

… a benign tissue reference in antigen discovery, especially for immunotherapy of cancer. Here, we extend the HLA Ligand Atlas resource with p…

… malignancy. Despite different guidelines recommending surgery, chemotherapy or immunotherapy, there has been no optimal first-line treatmen…

…Background Combining chemotherapy with immunotherapy is a promising strategy to enhance in situ immunity by increasi…

…The UK’s medicines regulator has approved the first immunotherapy to be licensed to delay the progression of type 1 diabetes in p…

…d in 2017, evaluated immune checkpoint inhibitors (ICIs) versus chemotherapy in the first-line treatment of non-small cell lung cancer (NSCL…

…stion, suggesting its potential as a therapeutic target for RCC immunotherapy.…